Related Experiment Video
Updated: Jan 16, 2026

Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS
Published on: July 11, 2016
Elizabethkingia miricola mediastinitis and bacteraemia
Grace Rothwell-Kelly1, Clarice Egan2, Kirsten Schaffer2
1Department of Clinical Microbiology, St. Vincent's University Hospital, Dublin, Ireland rothweg@tcd.ie.
None:
Elizabethkingia species, including Elizabethkingia miricola, are rare opportunistic Gram-negative bacteria. We present a case of E. miricola bloodstream infection associated with a polymicrobial mediastinitis. A male in his 70s underwent an elective Nissen fundoplication, deteriorated on day one post surgery and was transferred to the intensive care unit. Blood cultures revealed E. miricola A CT scan revealed an air and fluid collection posterior to the heart, moderate bilateral pleural effusions, an extensive pneumomediastinum, pockets of free air within the upper abdomen and a splenic infarct. A mediastinal drain and pleural drains were inserted, which cultured E. miricola, Candida albicans, Staphylococcus aureus and anaerobes. The patient was treated with piperacillin-tazobactam and fluconazole with a good response. E. miricola is intrinsically resistant to multiple antibiotic classes, including carbapenems and aminoglycosides. The lack of published cases combined with resistance makes management challenging. Our case highlighted the need for a combination of antibiotic therapy and source control.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Bacterial Signaling
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

